Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study

Table 4 Demographic and surgical characteristics of bariatric surgery eligible patients who were referred for surgery, n (%)

Patient characteristics		(+) Surgery	(-) Surgery	P value
Number of patients	n = 127	31	96
Sex	Male	6 (20)	32 (33)	0.14
	Female	25 (80)	64 (67)
Age in years, mean ± SD		49 ± 10.5	52 ± 13.1	0.248
Race	White	21 (68)	76 (79)	0.236
	Black	4 (13)	8 (8)
	Asian	1 (3)	0 (0)
	Other/declined	5 (16)	12 (13)
Ethnicity	Hispanic	6 (19)	20 (21)	0.86
	Non-Hispanic	25 (81)	76 (79)
Insurance status	Uninsured	0 (0)	0 (0)	0.035
	Medicaid	14 (46)	25 (26)
	Medicare	2 (6)	24 (25)
	Private	15 (48)	46 (49)
Median household income by zip code	< $50000	7 (23)	18 (19)	0.74
	$50000-$100000	19 (61)	66 (69)
	> $100000	5 (16)	12 (12)
Interventions and outcomes
Trialed anti-obesity medication	Lifetime	13 (42)	32 (33)	0.59
	Trialed since first FLDP visit	8 (26)	26 (27)
Surgery type	RYGB	10 (32)
	SG	21 (68)
Non-surgical weight loss method	Medication and lifestyle		41 (43)
	Lifestyle only		55 (57)
Nutrition referral	Since first FLDP visit	15 (48)	62 (65)
Mean BMI reduction (kg/m2), mean ± SD	RYGB	8.3 ± 5.4	1.3 ± 3.9	< 0.0001

Categorical variables compared using the χ² test. FLDP: Fatty liver disease program; RYGB: Roux-en-Y gastric bypass; SG: Sleeve gastrectomy; BMI: Body mass index.